TY - CONF A1 - Resch-Genger, Ute A1 - Wegner, Karl David A1 - Kalot, G. A1 - Busser, B. A1 - Pliquett, J. A1 - Köster, U. A1 - Koll, J. C. A1 - Denat, F. A1 - Bodio, E. A1 - Goze, C. A1 - Sacey, L. T1 - NIR aza-BODIPY: a new vector for boron neutron capture therapy (BNCT) N2 - Boron neutron capture therapy (BNCT) relies on the activation of 10B by thermal neutrons, which results in small highly energetic particle emission inducing cancer cells damage. However, in order to overcome the limits of the currently used BNCT agents, it is necessary to design new systems, which can specifically accumulate and deliver a sufficient amount of 10B in tumors. In this study, we designed a 10B-BSH-containing aza-BODIPY (aza-SWIR-BSH). It enabled the efficient vectorization of clinically used 10B-BSH to the tumor, resulting in higher therapeutic activity than the 10B-BSH alone. T2 - EMIM 2021 CY - Göttingen, Germany DA - 24.08.2021 KW - Flourescence KW - Optical probe KW - Dye KW - Photophysics KW - Quantum yield KW - Mechanism KW - NIR KW - SWIR KW - Imaging KW - Method KW - Quality assurance KW - BODIPY KW - Boron Neutron Capture Therapy (BNCT) KW - Medicine KW - Life sciences PY - 2021 AN - OPUS4-53731 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Bertorelle, F. A1 - Wegner, Karl David A1 - Berkulic, M. P. A1 - Fakhouri, H. A1 - Comby-Zerbino, C. A1 - Sagar, A. A1 - Bernadó, P. A1 - Resch-Genger, Ute A1 - Bonacic-Koutecký, V. A1 - Le Guével, X. A1 - Antoine, R. T1 - Tailoring the NIR-II Photoluminescence of Single Thiolated Au25 Nanoclusters by Selective Binding to Proteins N2 - Atomically precise gold nanoclusters are a fascinating class of nanomaterials that exhibit molecule-like properties and have outstanding photoluminescence (PL). Their ultrasmall size, molecular chemistry, and biocompatibility make them extremely appealing for selective biomolecule labeling in investigations of biological mechanisms at the cellular and anatomical levels. In this work, we report a simple route to incorporate a preformed Au25 nanocluster into a model bovine serum albumin (BSA) protein. A new approach combining small-angle X-ray scattering and molecular modeling provides a clear localization of a single Au25 within the protein to a cysteine residue on the gold nanocluster surface. Attaching Au25 to BSA strikingly modifies the PL properties with enhancement and a redshift in the second near-infrared (NIR-II) window. This study paves the way to conrol the design of selective sensitive probes in biomolecules through a ligand-based strategy to enable the optical detection of biomolecules in a cellular environment by live imaging. KW - Fluorescence KW - Aggregation KW - Signal enhancement KW - Cluster KW - Nano KW - Metal KW - NIRII KW - SWIR KW - Sensor KW - Quantum yield KW - Lifetime KW - Photophysics KW - Synthesis KW - Protein KW - Imaging KW - Bioimaging KW - Ligand KW - Gold PY - 2022 DO - https://doi.org/10.1002/chem.202200570 SN - 1521-3765 VL - 28 IS - 39 SP - 1 EP - 8 PB - Wiley-VCH CY - Weinheim AN - OPUS4-55077 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Mohammad, W. A1 - Wegner, Karl David A1 - Comby-Zerbino, C. A1 - Trouillet, V. A1 - Ogayer, M. P. A1 - Coll, J.-L. A1 - Marin, R. A1 - Jaque Garcia, D. A1 - Resch-Genger, Ute A1 - Antoine, R. A1 - Le Guevel, X. T1 - Enhanced brightness of ultra-small gold nanoparticles in the second biological window through thiol ligand shell control N2 - Gold-based nanoparticles below 2 nm in size are promising as luminescent probes for in vivo bioimaging, owing to their brightness and rapid renal clearance. However, their use as contrast agents in the near-infrared II (NIR-II, 1000–1700 nm) range remains challenging due to their low photoluminescence (PL) quantum yield. To address this, PL enhancement can be achieved by either rigidifying the ligand-shell structure or increasing the size of the ligand shell. In this study, we synthesized ultra-small gold nanoparticles stabilized by co-ligands, namely monothiol and short dithiol molecules. By precisely controlling the amount of reducing agent used during particle preparation, we successfully modulated the physicochemical properties of the co-ligand shell, including its size, composition, and structure. Consequently, we achieved a remarkable 60-fold increase in the absorption cross-section at 990 nm while maintaining the small size of the 1.5-nm metal core. The analytical and optical characterization of our thiol-capped gold nanoparticles indicates that the ligand shell size is governed by the quantity of the reducing agent, which, in turn, impacts the balance between radiative and non-radiative processes, thereby influencing the PL quantum yield. KW - Gold nanocluster KW - NIR-II fluorescence KW - SWIR KW - Nanomaterial design KW - Calibrated fluorescence measurements PY - 2023 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-588117 DO - https://doi.org/10.1039/D3TC03021K SN - 2050-7526 VL - 11 IS - 42 SP - 14714 EP - 14724 PB - Royal Society of Chemistry (RSC) AN - OPUS4-58811 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Godard, A. A1 - Kalot, G. A1 - Pliquett, J. A1 - Busser, B. A1 - Le Guével, X. A1 - Wegner, Karl David A1 - Resch-Genger, Ute A1 - Russelin, Y. A1 - Coll, J.-L. A1 - Denat, F. A1 - Bodio, E. A1 - Goze, C. A1 - Sancey, L. T1 - Water-Soluble Aza-BODIPYs: Biocompatible Organic Dyes for High Contrast In Vivo NIR-II Imaging N2 - A simple NIR-II emitting water-soluble system has been developed and applied in vitro and in vivo. In vitro, the fluorophore quickly accumulated in 2D and 3D cell cultures and rapidly reached the tumor in rodents, showing high NIR-II contrast for up to 1 week. This very efficient probe possesses all the qualities necessary for translation to the clinic as well as for the development of NIR-II emitting materials. KW - Aza-BODIPY KW - NIR-II Imaging KW - In vivo imaging KW - organic dyes KW - SWIR KW - Cancer KW - Fluorescence PY - 2020 DO - https://doi.org/10.1021/acs.bioconjchem.0c00175 VL - 31 IS - 4 SP - 1088 EP - 1092 PB - ACS Publications AN - OPUS4-50695 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Kalot, G. A1 - Godard, A. A1 - Busser, B. A1 - Pliquett, J. A1 - Broekgaarden, M. A1 - Motto-Ros, V. A1 - Wegner, Karl David A1 - Resch-Genger, Ute A1 - Köster, U. A1 - Denat, F. A1 - Coll, J.-L. A1 - Bodio, E. A1 - Goze, C. A1 - Sancey, L. T1 - Aza-BODIPY: A New Vector for Enhanced Theranostic Boron Neutron Capture Therapy Applications N2 - Boron neutron capture therapy (BNCT) is a radiotherapeutic modality based on the nuclear capture of slow neutrons by stable 10B atoms followed by charged particle Emission that inducing extensive damage on a very localized level (<10 um). To be effcient, a suffcient amount of 10B should accumulate in the tumor area while being almost cleared from the normal surroundings. A water-soluble aza-boron-dipyrromethene dyes (BODIPY) fluorophore was reported to strongly accumulate in the tumor area with high and BNCT compatible Tumor/Healthy Tissue ratios. The clinically used 10B-BSH (sodium borocaptate) was coupled to the water-soluble aza-BODIPY platform for enhanced 10B-BSH tumor vectorization. We demonstrated a strong uptake of the compound in tumor cells and determined its biodistribution in mice-bearing tumors. A model of chorioallantoic membrane-bearing glioblastoma xenograft was developed to evidence the BNCT potential of such compound, by subjecting it to slow neutrons. We demonstrated the Tumor accumulation of the compound in real-time using optical imaging and ex vivo using elemental imaging based on laser-induced breakdown spectroscopy. The tumor growth was significantly reduced as compared to BNCT with 10B-BSH. Altogether, the fluorescent aza-BODIPY/10B-BSH compound is able to vectorize and image the 10B-BSH in the tumor area, increasing its theranostic potential for effcient approach of BNCT. KW - Aza-BODIPY KW - SWIR KW - NIR-I KW - Theranostic KW - Boron compound KW - Optical imaging PY - 2020 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-512280 DO - https://doi.org/10.3390/cells9091953 VL - 9 IS - 9 SP - 1953 PB - MDPI AN - OPUS4-51228 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Le Guevel, X. A1 - Wegner, Karl David A1 - Würth, Christian A1 - Baulin, V. A. A1 - Musnier, B. A1 - Josserand, V. A1 - Resch-Genger, Ute A1 - Koll, J-C T1 - Tailoring the SWIR emission of gold nanoclusters by surface ligand rigidification and their application in 3D bioimaging N2 - The influence of solvent polarity and surface ligand rigidification on the SWIR emission profile of gold nanoclusters with an anistropic surface was investigated. A strong enhancement of the SWIR emission band at 1200 nm was observed when measuring in different local environments: in solution, in polymer composites, and in solids. SWIR in vivo imaging of mice assisted by deep learning after intravenous administration of these gold nanoclusters provides high definition pseudo-3D views of vascular blood vessels. KW - Nano KW - Nanomaterial KW - Metal cluster KW - Photoluminescence KW - Quantum yield KW - Photophysics KW - Lifetime KW - Sensor KW - NIR KW - SWIR KW - Ligand KW - Gold KW - Mechanism KW - Charge transfer KW - Enhancement strategy KW - Imaging KW - Application KW - Contrast agent PY - 2022 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-543582 DO - https://doi.org/10.1039/D1CC06737K VL - 58 IS - 18 SP - 2967 EP - 2970 PB - RSC AN - OPUS4-54358 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -